ALLMedicine™ Atopic Dermatitis Center
Research & Reviews 13,237 results
https://doi.org/10.1186/s12879-021-06044-4 10.1016/j.jid.2017.09.023 10.3906/sag-1810-105 10.1159/000370220 10.1016/j.jaci.2007.11.004 10.1016/j.jaci.2019.07.048 10.1016/j.it.2015.10.006 10.1007/s10096-016-2672-2 10.1111/bjd.14566 10.1016/j.jid.2017.07.834 10.1016/j.tim.2017.11.008 10.1111/bjd.15390 10.1016/j.micinf.2010.10.023 10.1016/j.jaci.2018.07.023 10.1111/j.1365-2133.1994.tb08532.x 10.1159/000323308 10.1016/j.anai.2015.06.003 10.1371/journal.pone.0068097 10.1186/1476-0711-9-23 10.1016/j.meegid.2011.09.002 10.1128/JCM.30.7.1654-1660.1992 10.1128/JCM.42.2.792-799.2004 10.1111/j.1469-0691.2011.03715.x 10.1186/1471-2180-14-63 10.1128/JCM.37.11.3556-3563.1999 10.1186/1471-2180-7-98 10.1038/s41598-018-27421-1 10.1016/j.jaci.2015.07.052 10.1155/2011/718708 10.26444/aaem/85589 10.7860/JCDR/2013/5506.3371 10.1111/bjd.15470 10.5812/jjm.20760v2 10.5021/ad.2013.25.4.410 10.1101/gr.131029.111 10.3389/fmicb.2017.01162 10.1186/s40413-015-0071-2 10.1016/j.meegid.2013.03.020 10.1007/s10096-013-1882-0 10.1111/j.1749-6632.2012.06724.x 10.1111/j.1365-4632.2011.05176.x 10.1080/10937404.2012.710134 10.1016/j.envres.2015.06.006 10.1029/2019GH000208 10.1016/j.meegid.2013.02.013 10.1128/JCM.01822-07 10.1016/j.bjid.2015.08.006 10.1128/JCM.00820-09 10.1179/1973947815Y.0000000044 10.1371/journal.pone.0096119 10.1111/j.1346-8138.2009.00592.x 10.1111/j.1469-0691.2011.03534.x
BMC Infectious Diseases; Ndhlovu GON, Abotsi RE et. al.
Apr 14th, 2021 - Staphylococcus aureus has been associated with the exacerbation and severity of atopic dermatitis (AD). Studies have not investigated the colonisation dynamics of S. aureus lineages in African toddlers with AD. We determined the prevalence and pop...
https://doi.org/10.1001/jamadermatol.2021.0008
JAMA Dermatology; Wan J, Mitra N et. al.
Apr 14th, 2021 - Recent population-based data indicate that atopic dermatitis (AD) is associated with learning disability (LD) in children, but the association between AD severity and LD is unknown. To evaluate the association of AD severity with learning problems...
https://doi.org/10.1001/jamadermatol.2021.0009
JAMA Dermatology; Schmidt SAJ, Mailhac A et. al.
Apr 14th, 2021 - Atopic dermatitis (AD) may affect academic performance through multiple pathways, including poor concentration associated with itching, sleep deprivation, or adverse effects of medications. Because educational attainment is associated with health ...
https://doi.org/10.1001/jamadermatol.2021.0007
JAMA Dermatology; Abuabara K
Apr 14th, 2021 - Atopic Dermatitis and Academic Achievement-More to Learn.|2021|Abuabara K,|
https://doi.org/10.1080/09546634.2021.1914315
The Journal of Dermatological Treatment; Husein-ElAhmed H, Steinhoff M
Apr 14th, 2021 - Atopic dermatitis (AD) is a very common chronic inflammatory skin disease. Ustekinumab is a human monoclonal antibody approved for psoriasis, that targets the p40 subunit shared by interleukin (IL)-12 and IL-23, cytokines which may also play a rol...
Guidelines 35 results
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.
Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...
https://www.dermnetnz.org/topics/atopic-dermatitis/
Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.
Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al
Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...
https://doi.org/10.1542/peds.2019-0281
Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...
Drugs 625 results see all →
Clinicaltrials.gov 14,449 results
https://doi.org/10.1186/s12879-021-06044-4 10.1016/j.jid.2017.09.023 10.3906/sag-1810-105 10.1159/000370220 10.1016/j.jaci.2007.11.004 10.1016/j.jaci.2019.07.048 10.1016/j.it.2015.10.006 10.1007/s10096-016-2672-2 10.1111/bjd.14566 10.1016/j.jid.2017.07.834 10.1016/j.tim.2017.11.008 10.1111/bjd.15390 10.1016/j.micinf.2010.10.023 10.1016/j.jaci.2018.07.023 10.1111/j.1365-2133.1994.tb08532.x 10.1159/000323308 10.1016/j.anai.2015.06.003 10.1371/journal.pone.0068097 10.1186/1476-0711-9-23 10.1016/j.meegid.2011.09.002 10.1128/JCM.30.7.1654-1660.1992 10.1128/JCM.42.2.792-799.2004 10.1111/j.1469-0691.2011.03715.x 10.1186/1471-2180-14-63 10.1128/JCM.37.11.3556-3563.1999 10.1186/1471-2180-7-98 10.1038/s41598-018-27421-1 10.1016/j.jaci.2015.07.052 10.1155/2011/718708 10.26444/aaem/85589 10.7860/JCDR/2013/5506.3371 10.1111/bjd.15470 10.5812/jjm.20760v2 10.5021/ad.2013.25.4.410 10.1101/gr.131029.111 10.3389/fmicb.2017.01162 10.1186/s40413-015-0071-2 10.1016/j.meegid.2013.03.020 10.1007/s10096-013-1882-0 10.1111/j.1749-6632.2012.06724.x 10.1111/j.1365-4632.2011.05176.x 10.1080/10937404.2012.710134 10.1016/j.envres.2015.06.006 10.1029/2019GH000208 10.1016/j.meegid.2013.02.013 10.1128/JCM.01822-07 10.1016/j.bjid.2015.08.006 10.1128/JCM.00820-09 10.1179/1973947815Y.0000000044 10.1371/journal.pone.0096119 10.1111/j.1346-8138.2009.00592.x 10.1111/j.1469-0691.2011.03534.x
BMC Infectious Diseases; Ndhlovu GON, Abotsi RE et. al.
Apr 14th, 2021 - Staphylococcus aureus has been associated with the exacerbation and severity of atopic dermatitis (AD). Studies have not investigated the colonisation dynamics of S. aureus lineages in African toddlers with AD. We determined the prevalence and pop...
https://doi.org/10.1001/jamadermatol.2021.0008
JAMA Dermatology; Wan J, Mitra N et. al.
Apr 14th, 2021 - Recent population-based data indicate that atopic dermatitis (AD) is associated with learning disability (LD) in children, but the association between AD severity and LD is unknown. To evaluate the association of AD severity with learning problems...
https://doi.org/10.1001/jamadermatol.2021.0009
JAMA Dermatology; Schmidt SAJ, Mailhac A et. al.
Apr 14th, 2021 - Atopic dermatitis (AD) may affect academic performance through multiple pathways, including poor concentration associated with itching, sleep deprivation, or adverse effects of medications. Because educational attainment is associated with health ...
https://doi.org/10.1001/jamadermatol.2021.0007
JAMA Dermatology; Abuabara K
Apr 14th, 2021 - Atopic Dermatitis and Academic Achievement-More to Learn.|2021|Abuabara K,|
https://doi.org/10.1080/09546634.2021.1914315
The Journal of Dermatological Treatment; Husein-ElAhmed H, Steinhoff M
Apr 14th, 2021 - Atopic dermatitis (AD) is a very common chronic inflammatory skin disease. Ustekinumab is a human monoclonal antibody approved for psoriasis, that targets the p40 subunit shared by interleukin (IL)-12 and IL-23, cytokines which may also play a rol...
News 1,507 results
https://www.medscape.com/viewarticle/949207
Apr 12th, 2021 - The American Academy of Pediatrics recently issued five recommendations for the most common dermatologic problems in primary care pediatrics. Topics include diagnostic and management strategies for a variety of conditions, including atopic dermati...
https://www.medscape.com/viewarticle/948892
Apr 7th, 2021 - (Reuters) - Pfizer Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had extended the review of its experimental atopic dermatitis drug by three months, the latest regulatory setback for a class of treatments known as JAK inhibitor...
https://www.medscape.com/viewarticle/948150
Mar 24th, 2021 - An experimental oral Janus kinase 1 (JAK1) inhibitor, abrocitinib, showed greater itch reduction after 2 weeks of treatment than dupilumab in patients with moderate to severe atopic dermatitis (AD), in a multicenter, randomized trial. An experimen...
https://www.medscape.com/viewarticle/948020
Mar 23rd, 2021 - Ruxolitinib cream, an investigational selective Janus kinase 1 and 2 inhibitor now under priority review by the Food and Drug Administration for the treatment of atopic dermatitis (AD) down to age 12 years, demonstrated a dual mechanism of action ...
https://reference.medscape.com/viewarticle/947391
Mar 17th, 2021 - In patients with skin of color, atopic dermatitis appears with various clinical manifestations. Erythema may be difficult to see or may appear violaceous. Inflammation from atopic dermatitis may result in hypopigmentation or hyperpigmentation of t...